Search research articles
Contact Us
Filters
Showing results (71-80 of 92) with videos related to
Page
of 10
Sort By:
The International Journal of Neuroscience
|
April 1, 1990
Human T cell intrathymic ontogeny: differences between myasthenic and normal thymus
L Durelli, M F Ferrio, U Massazzá, et al.
Acta Neurologica Scandinavica
|
March 10, 2001
Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy
G Isoardo, B Ferrero, P Barbero, et al.
Journal of the Neurological Sciences
|
November 1, 1996
Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
M R Bongioanni, L Durelli, B Ferrero, et al.
Annals of Neurology
|
February 1, 1990
Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis
L Durelli, U Massazza, G Poccardi, et al.
Acta Neurologica Scandinavica
|
May 2, 2002
Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment
Paolopiero Limone, B Ferrero, P Calvelli, et al.
Neurology
|
February 1, 1986
High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations
L Durelli, D Cocito, A Riccio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS study
L Durelli, A Oggero, E Verdun, et al.
Annals of Neurology
|
September 1, 1994
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
E Nobile-Orazio, E Manfredini, M Carpo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab
P Barbero, M Bergui, E Versino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 1, 1995
Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study
G Comi, F Barkhof, L Durelli, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 92) with videos related to
Sort By:
Page
of 10
The International Journal of Neuroscience
|
April 1, 1990
Human T cell intrathymic ontogeny: differences between myasthenic and normal thymus
L Durelli, M F Ferrio, U Massazzá, et al.
Acta Neurologica Scandinavica
|
March 10, 2001
Anti-GM1 and anti-sulfatide antibodies in polyneuropathies. Threshold titers and accuracy
G Isoardo, B Ferrero, P Barbero, et al.
Journal of the Neurological Sciences
|
November 1, 1996
Systemic high-dose recombinant-alpha-2a-interferon therapy modulates lymphokine production in multiple sclerosis
M R Bongioanni, L Durelli, B Ferrero, et al.
Annals of Neurology
|
February 1, 1990
Increased thymocyte differentiation in myasthenia gravis: a dual-color immunofluorescence phenotypic analysis
L Durelli, U Massazza, G Poccardi, et al.
Acta Neurologica Scandinavica
|
May 2, 2002
Hypothalamic-pituitary-adrenal axis function and cytokine production in multiple sclerosis with or without interferon-beta treatment
Paolopiero Limone, B Ferrero, P Calvelli, et al.
Neurology
|
February 1, 1986
High-dose intravenous methylprednisolone in the treatment of multiple sclerosis: clinical-immunologic correlations
L Durelli, D Cocito, A Riccio, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
|
October 18, 2001
Interferon-beta dose and efficacy: the OPTIMS study
L Durelli, A Oggero, E Verdun, et al.
Annals of Neurology
|
September 1, 1994
Frequency and clinical correlates of anti-neural IgM antibodies in neuropathy associated with IgM monoclonal gammopathy
E Nobile-Orazio, E Manfredini, M Carpo, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
February 8, 2006
Every-other-day interferon beta-1b versus once-weekly interferon beta-1a for multiple sclerosis (INCOMIN Trial) II: analysis of MRI responses to treatment and correlation with Nab
P Barbero, M Bergui, E Versino, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|
January 1, 1995
Early treatment of multiple sclerosis with Rebif (recombinant human interferon beta): design of the study
G Comi, F Barkhof, L Durelli, et al.
Page
of 10